← Evidence map

ArticleDiabetologia2017

The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE

Ji Hye Han et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

150 papers cite itlatest 60 shown

2017
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27866224